{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:20:14Z","timestamp":1787678414467,"version":"build-2784847793"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The study aimed to assess the prevalence, clinical characteristics, and therapeutic outcomes of the central nervous system (CNS) demyelinating disease in a large cohort of primary Sj\u00f6gren's syndrome (pSS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is an explorative cross-sectional study of patients with pSS seen in the departments of rheumatology, otorhinolaryngology, or neurology of a tertiary university center between January 2015 and September 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In a cohort of 194 pSS patients, 22 patients had a CNS manifestation. In this CNS group, 19 patients had a lesion pattern suggestive of demyelination. While there were no obvious differences in the patients' epidemiological disposition or rate of other extraglandular manifestations, the CNS group differed from the remaining patients with pSS by having less glandular manifestations but a higher seroprevalence for anti-SSA\/Ro antibodies. Notably, patients with CNS manifestations were often diagnosed with multiple sclerosis (MS) and treated as such, although age and disease course were atypical of MS. Many first-line MS agents were ineffective in these \u201cMS look-alikes\u201d; however, the disease course was benign with B-cell-depleting agents.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Neurological symptoms of pSS are common and clinically manifest mainly as myelitis or optic neuritis. Notably, in the CNS, the pSS phenotype can overlap with MS. The prevailing disease is crucial since it has a major impact on the long-term clinical outcome and the choice of disease-modifying agents. Although our observations neither confirm pSS as a more appropriate diagnosis nor rule out simple comorbidity, physicians should consider pSS in the extended diagnostic workup of CNS autoimmune diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2023.1128315","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T07:33:04Z","timestamp":1676532784000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["CNS demyelinating events in primary Sj\u00f6gren's syndrome: A single-center case series on the clinical phenotype"],"prefix":"10.3389","volume":"14","author":[{"given":"Ali M.","family":"Afzali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Moog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhakar Reddy","family":"Kalluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Hofauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Knopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Stefan","family":"Kirschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Hemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"Berthele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/acr.22968","article-title":"Treatment guidelines for rheumatologic manifestations of sjogren's syndrome: use of biologic agents, management of fatigue, and inflammatory musculoskeletal pain","volume":"69","author":"Carsons","year":"2017","journal-title":"Arthritis Care Res."},{"key":"B2","first-page":"121","article-title":"Severe, life-threatening phenotype of primary Sjogren's syndrome: clinical characterisation and outcomes in 1580 patients (GEAS-SS Registry)","volume":"36","author":"Flores-Chavez","year":"2018","journal-title":"Clin Exp Rheumatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1093\/rheumatology\/keab364","article-title":"Mortality in patients with primary Sjogren's syndrome: a systematic review and meta-analysis","volume":"60","author":"Huang","year":"2021","journal-title":"Rheumatology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1093\/rheumatology\/kev354","article-title":"Rate, risk factors and causes of mortality in patients with Sjogren's syndrome: a systematic review and meta-analysis of cohort studies","volume":"55","author":"Singh","year":"2016","journal-title":"Rheumatology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1136\/ard.2009.110619","article-title":"EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome","volume":"69","author":"Seror","year":"2010","journal-title":"Ann Rheum Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1093\/rheumatology\/kex163","article-title":"The British Society for Rheumatology guideline for the management of adults with primary Sjogren's syndrome","volume":"56","author":"Price","year":"2017","journal-title":"Rheumatology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sjogren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B8","first-page":"102","article-title":"How immunological profile drives clinical phenotype of primary Sj\u00f6gren's syndrome at diagnosis: analysis of 10,500 patients (Sj\u00f6gren Big Data Project)","volume":"36","author":"Brito-Zer\u00f3n","year":"2018","journal-title":"Clin Exp Rheumatol."},{"key":"B9","first-page":"97","article-title":"Systemic manifestations of primary Sjogren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients","volume":"37","author":"Retamozo","year":"2019","journal-title":"Clin Exp Rheumatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/nrrheum.2016.100","article-title":"Treatment of primary Sjogren syndrome","volume":"12","author":"Saraux","year":"2016","journal-title":"Nat Rev Rheumatol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216114","article-title":"EULAR recommendations for the management of Sjogren's syndrome with topical and systemic therapies","author":"Ramos-Casals","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1136\/annrheumdis-2012-202293","article-title":"Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry","volume":"72","author":"Gottenberg","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.clim.2017.05.002","article-title":"The value of rituximab treatment in primary Sjogren's syndrome","volume":"182","author":"Verstappen","year":"2017","journal-title":"Clin Immunol."},{"key":"B16","first-page":"19","article-title":"The Big Data Sj\u00f6gren Consortium: a project for a new data science era","volume":"37","author":"Acar-Denizli","year":"2019","journal-title":"Clin Exp Rheumatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2013-204615","article-title":"Validation of EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)","volume":"74","author":"Seror","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"20552173211022767","DOI":"10.1177\/20552173211022767","article-title":"Frequency of myelin oligodendrocyte glycoprotein antibodies in a large cohort of neurological patients","volume":"7","author":"Held","year":"2021","journal-title":"Mult Scler J Exp Transl Clin."},{"key":"B19","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.nic.2011.07.010","article-title":"Neuroimaging in acute transverse myelitis","volume":"21","author":"Goh","year":"2011","journal-title":"Neuroimaging Clin N Am"},{"key":"B20","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nrneurol.2011.176","article-title":"Longitudinal extensive transverse myelitis\u2013it's not all neuromyelitis optica","volume":"7","author":"Trebst","year":"2011","journal-title":"Nat Rev Neurol."},{"key":"B21","volume-title":"Central Nervous System Disease in Sj\u00f6gren's Syndrome. Annales de M\u00e9decine Interne.","author":"Escudero","year":"1995"},{"key":"B22","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s10067-010-1458-7","article-title":"Clinical manifestations of neurological involvement in primary Sjogren's syndrome","volume":"30","author":"Gono","year":"2011","journal-title":"Clin Rheumatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ejim.2013.10.005","article-title":"Immunological profiles determine neurological involvement in Sjogren's syndrome","volume":"25","author":"Jamilloux","year":"2014","journal-title":"Eur J Intern Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1093\/rheumatology\/keq111","article-title":"Central nervous system involvement in Sjogren's syndrome: unusual, but not unremarkable\u2013clinical, serological characteristics and outcomes in a large cohort of Italian patients","volume":"49","author":"Massara","year":"2010","journal-title":"Rheumatology."},{"key":"B25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00296-014-3097-9","article-title":"Frequent involvement of central nervous system in primary Sjogren syndrome","volume":"35","author":"Moreira","year":"2015","journal-title":"Rheumatol Int."},{"key":"B26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12868-018-0427-y","article-title":"Clinical features and risk factors of neurological involvement in Sjogren's syndrome","volume":"19","author":"Ye","year":"2018","journal-title":"BMC Neurosci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1600-0404.1994.tb01629.x","article-title":"Neurological and neuropsychiatric dysfunction in primary Sj\u00f6gren's syndrome","volume":"89","author":"Mauch","year":"2009","journal-title":"Acta Neurol Scand."},{"key":"B28","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/art.10561","article-title":"Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing","volume":"47","author":"Solomon","year":"2002","journal-title":"Arthritis Rheum."},{"key":"B29","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1177\/0961203311427550","article-title":"Antinuclear and antiphospholipid antibodies in patients with multiple sclerosis","volume":"21","author":"Szmyrka-Kaczmarek","year":"2011","journal-title":"Lupus."},{"key":"B30","first-page":"888","article-title":"Primary Sjogren's syndrome related optic neuritis","volume":"6","author":"Tang","year":"2013","journal-title":"Int J Ophthalmol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.3390\/jcm9051482","article-title":"Clinical, radiological, and laboratory features of spinal cord involvement in primary Sjogren's syndrome","volume":"9","author":"Butryn","year":"2020","journal-title":"J Clin Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"857014","DOI":"10.3389\/fimmu.2022.857014","article-title":"The shared mechanism and candidate drugs of multiple sclerosis and Sjogren's syndrome analyzed by bioinformatics based on GWAS and transcriptome data","volume":"13","author":"Hong","year":"2022","journal-title":"Front Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S1474-4422(10)70135-6","article-title":"Emerging effects of comorbidities on multiple sclerosis","volume":"9","author":"Marrie","year":"2010","journal-title":"Lancet Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1177\/1352458514564490","article-title":"A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult Scler."},{"key":"B35","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3389\/fneur.2020.00851","article-title":"Comorbidity in multiple sclerosis","volume":"11","author":"Magyari","year":"2020","journal-title":"Front Neurol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1136\/annrheumdis-2015-207499","article-title":"A review of salivary gland histopathology in primary Sjogren's syndrome with a focus on its potential as a clinical trials biomarker","volume":"74","author":"Fisher","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/mus.10470","article-title":"Positive salivary gland biopsy, Sjogren syndrome, and neuropathy: clinical implications","volume":"28","author":"Gorson","year":"2003","journal-title":"Muscle Nerve."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e0084605","DOI":"10.1371\/journal.pone.0084605","article-title":"Neurological involvement in primary sj\u00f6gren syndrome: a focus on central nervous system","volume":"9","author":"Morreale","year":"2014","journal-title":"PLoS ONE"},{"key":"B39","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3390\/brainsci9040085","article-title":"Cognitive function in primary sjogren's syndrome: a systematic review","volume":"9","author":"Manzo","year":"2019","journal-title":"Brain Sci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/1756-185X.13889","article-title":"Cognitive dysfunction in Sjogren's syndrome using the montreal cognitive assessment questionnaire and the automated neuropsychological assessment metrics: a cross-sectional study","volume":"23","author":"Riega-Torres","year":"2020","journal-title":"Int J Rheum Dis"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1128315\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T07:33:15Z","timestamp":1676532795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1128315\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":40,"alternative-id":["10.3389\/fneur.2023.1128315"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1128315","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,16]]},"article-number":"1128315"}}